| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Robin Howard W serves as a President &CEO at NKTR. Across recent SEC filings that breaks down to 0 buys and 97 sells. Those positions are worth an estimated $5.8M at current prices.
Historically, Robin Howard W's trades have earned a middling insider score of 58/100 across 25 rated trades. Over a 12-month horizon, 47.4% of those trades were profitable, with an average 12-month return of -8.4%.
The biggest single holding is NKTR (~$5.8M) as President &CEO. The recent filings there lean toward selling, a net 3,591,677 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2018 | NKTR Nektar Therapeutics | President &CEO | Sell | 12,788 | $82.94 | $1,060,636.72 | -5.1% | |
| Jan 22, 2018 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 83,333 | $75.82 | $6,318,308.06 | -25.0% | |
| Dec 13, 2017 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 83,333 | $55.69 | $4,640,814.77 | -30.6% | |
| Nov 1, 2017 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 83,334 | $23.57 | $1,964,182.38 | -35.3% | |
| Oct 9, 2017 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 83,333 | $24.20 | $2,016,658.60 | -35.3% | |
| Sep 6, 2017 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 83,333 | $21.54 | $1,794,992.82 | -35.3% | |
| Aug 16, 2017 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 91,714 | $19.26 | $1,766,081.10 | -23.1% | |
| May 16, 2017 | NKTR Nektar Therapeutics | President &CEO | Sell | 8,388 | $19.55 | $163,985.40 | -5.0% | |
| Feb 16, 2017 | NKTR Nektar Therapeutics | President &CEO | Sell | 8,636 | $13.14 | $113,477.04 | -4.9% | |
| Feb 8, 2017 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 87,500 | $13.04 | $1,141,000.00 | -33.0% |